Status:
RECRUITING
Prophylactic Surfactant by Thin Endotracheal Catheter for Preterm Infants At Birth: the ProTeCt Trial
Lead Sponsor:
University College Dublin
Conditions:
Infant, Newborn, Diseases
Prematurity
Eligibility:
All Genders
Up to 30 years
Phase:
NA
Brief Summary
The goal of this clinical trial is to learn whether giving surfactant through a thin endotracheal catheter to extremely premature babies shortly after birth reduces the number of them who are ventilat...
Detailed Description
Preterm infants - particularly those born before 28 weeks of gestation - are at risk of developing respiratory distress syndrome (RDS), a condition characterised by structural and functional lung imma...
Eligibility Criteria
Inclusion
- Inclusion criteria
- Infants of any sex born before 28 weeks of gestation
- Clinicians plan to provide intensive care
- Consent for their participation provided by parent(s)/guardian(s) before their birth
- Exclusion criteria
- • Major congenital anomalies (e.g. upper airway anomaly, diaphragmatic hernia, gastroschisis, exomphalos major, intestinal atresias, open neural tube defect, aneuploidy, cardiac lesions other than ASD/PFO/VSD/PDA )
Exclusion
Key Trial Info
Start Date :
August 19 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 28 2027
Estimated Enrollment :
164 Patients enrolled
Trial Details
Trial ID
NCT06557551
Start Date
August 19 2024
End Date
February 28 2027
Last Update
October 15 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Maternity Hospital
Dublin, None Selected, Ireland, D02 YH21